Device Trial Radar · NCT04969822
eValuating iDA Selection Ability. The VISA Study.
Last checked: Nov 19, 2026Latest source record: Dec 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,066
Actual
Start
Feb 20, 2020
Primary completion
Jan 24, 2023
Study completion Nov 1, 2023
Sponsor
- Lead sponsor
- VitrolifeNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 21, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.
Conditions
- IVF
- Infertility
Interventions
iDAScore®Device
A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical Pregnancy RateTime frame: After 7-9 weeks of gestation
Locations
14 sites in 4 countries. Site status is shown where the registry gives one.
IVFAustralia Greenwich
Sydney, Greenwich, Australia
IVFAustralia Alexandria
Alexandria, New South Wales, Australia
IVFAustralia, Westmead
Sydney, New South Wales, Australia
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.